The University of Manchester is a founding partner of the Kenya-UK Healthcare Alliance, which aims to share best practice and reciprocal training between the two nations, particularly in the area of cancer care. In this article, from our On Cancer publication, Professor Keith Brennan, Dr F. George Njoroge, and Professor Rob Bristow outline how these […]
Advancing cell and gene therapies: Levelling-up life sciences investment in the North-West
Life sciences – including new cancer treatments – forms a central pillar of the UK Government’s post-Brexit plan for science and technology. But how could this focus also play a role in another key tenet of British policymaking; the levelling-up agenda? In this blog, adapted from our On Cancer publication, Professor Fiona Thistlethwaite and Professor […]
Saving lives and money through early detection: Lynch syndrome case study
A new national standard for cancer testing in England and Wales (NICE ‘Diagnostic Guidance 42’) was published in October 2020, following a successful policy engagement campaign from Professor Emma Crosbie’s team at The University of Manchester, and Policy@Manchester. In this piece, adapted from our On Cancer publication, Professor Crosbie explains why this is just the […]
Data directly from our patients: Is improving patient data the key to better cancer care?
To provide the best care and support for cancer patients during and after treatment, it is essential to collect and work with data that captures patient experiences and patient-reported outcomes. But data is not a simple subject. The way healthcare services work with data, and how we work with patients to collect it, must be […]
Rules of the road: The need for new quality standards for AI technology in healthcare
In recent years, we have seen a profusion of AI, algorithm, and machine-learning technologies enter clinical practice. This has happened across the health and care sector, and cancer testing and treatments have been no exception, with some proven benefits. For example, AI has been shown to be capable of recognising patterns in scan images that […]
Advanced radiotherapies: What are the challenges and opportunities?
Advanced radiotherapies are redefining the kinds of cancer treatment that are possible. These developments are exciting, but they also present new challenges. One challenge for researchers and clinicians is how to support policymakers, tasked with developing treatment and care standards across the NHS. So, what are these new treatments, what do they mean for patient […]
Access and inclusion: Can we move cancer services closer to home?
Traditionally, the vast majority of cancer services take place in hospitals, but new thinking and new technology are rapidly changing this landscape, particularly because of the impact of COVID-19 on the delivery of healthcare services. In this blog, from our On Cancer publication, Dr Philip Crosbie and Dr Dónal Landers outlines how delivering services at […]
Disadvantage and disease: finding solutions to inequalities in cancer
The COVID-19 pandemic has brought renewed focus to the great health inequalities between different communities in our society. Looking at cancer care, these inequalities exist across the whole cancer pathway from uptake in screening, likelihood to present early with symptoms, participation in clinical trials, diagnosis and access to treatments. In this blog, from our On […]